Market Size of Global Insufflation Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 6.30 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Insufflation Devices Market Analysis
The insufflation devices market is projected to register a CAGR of 6.3% during the forecast period (2022-2027).
The COVID-19 epidemic and the resulting restrictions have altered how healthcare systems operate worldwide. The continuing "coronavirus disease 19" (COVID-19) pandemic has had a significant impact on surgical care delivery around the world. Elective operations have been postponed to devote more resources to COVID-19 patients. According to a research article published in July 2021 titled "Impact of the COVID-19 Pandemic on the Patient's Decision about Bariatric Surgery: Results of a National Survey," bariatric operations were withdrawn in most countries after the International Federation for the Surgery of Obesity, and Metabolic Disorders issued recommendations (IFSO). Approximately 60,000 bariatric procedures per month may have been postponed globally. After a few months, several governments have begun to ease restrictions, such as reopening businesses and public areas, permitting social interaction, and allowing elective surgery to resume. As a result, COVID-19 significantly impacted the market for insufflation devices at the start of the pandemic.
Due to technological developments in surgery, an increase in the number of surgical cases, and an increase in the frequency of uterine fibroids, obesity, and cardiac diseases around the world, the need for insufflation devices is rising. One of the major factors driving market expansion is the rising incidence of obesity due to a sedentary lifestyle and an increase in the consumption of energy-dense meals high in fat and sugar. According to the Trust for America's Health, the adult obesity rate in the United States reached 42.4 percent in 2020, marking the first time the national percentage exceeded 40%.
As insufflation devices are used in bariatric surgery, the rising prevalence of obese persons with a BMI of 35-39 who have certain major health concerns, such as type 2 diabetes, sleep apnea, and high blood pressure, is a high-impact driver of the market. According to the World Health Organization in June 2021, there were 39 million under-five years old kids who were overweight or obese in 2020. Moreover, World Obesity Atlas March 2022 published by the World Obesity Federation, predicts that by 2030, one billion people worldwide, including one in five women and one in seven men, will have obesity. Furthermore, as the public becomes more aware of the benefits of bariatric surgery, the demand for insufflation devices as a treatment option has grown.
Insufflation Devices Industry Segmentation
As per the scope of this report, insufflation is the act of blowing gas, powder, or vapor into a body cavity. Gases are often insufflated into a body cavity to inflate the cavity for more workroom during various surgery. The Insufflation Devices Market is Segmented by Application (Laparoscopic, Endoscopic, and Others), End-users (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.
By Application | |
Laproscopic Surgery | |
Endoscopic Surgery | |
Others |
By End Use | |
Hospitals | |
Clinics | |
Ambulatory Surgical Center |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Insufflation Devices Market Size Summary
The insufflation devices market is experiencing growth driven by technological advancements in surgical procedures and an increasing number of surgical cases globally. The demand for these devices is particularly rising due to the growing prevalence of conditions such as uterine fibroids, obesity, and cardiac diseases, which necessitate surgical interventions. The market has been impacted by the COVID-19 pandemic, which led to the postponement of elective surgeries, including bariatric procedures. However, as restrictions have eased and elective surgeries have resumed, the market is expected to recover and expand. The rising incidence of obesity, fueled by sedentary lifestyles and unhealthy dietary habits, is a significant factor propelling the market, as insufflation devices are essential in bariatric surgeries. The increasing awareness and acceptance of bariatric surgery as a treatment option further contribute to the market's growth.
The laparoscopic surgery segment is anticipated to witness significant growth, driven by the benefits of minimally invasive procedures, such as reduced postoperative pain and shorter hospital stays. Insufflation devices are crucial in these surgeries, which are increasingly performed on high-risk patients, including the elderly and those with preexisting conditions. The market is also supported by advancements in technology, with innovations like Stryker's PneumoSure XL insufflator enhancing performance and safety. North America is a key region for market growth, attributed to its developed healthcare infrastructure and the presence of leading industry players. The market is competitive and fragmented, with major companies like STERIS, Stryker, and Medtronic actively participating. Regulatory approvals, such as those from the FDA, are facilitating the expansion of insufflation technology applications, further boosting market prospects.
Global Insufflation Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Global Increase in the Prevalence of Laparoscopic Procedures
-
1.2.2 Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 Gas insufflation-related complications
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Application
-
2.1.1 Laproscopic Surgery
-
2.1.2 Endoscopic Surgery
-
2.1.3 Others
-
-
2.2 By End Use
-
2.2.1 Hospitals
-
2.2.2 Clinics
-
2.2.3 Ambulatory Surgical Center
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Insufflation Devices Market Size FAQs
What is the current Global Insufflation Devices Market size?
The Global Insufflation Devices Market is projected to register a CAGR of 6.30% during the forecast period (2024-2029)
Who are the key players in Global Insufflation Devices Market?
Medtronic , STERIS , Stryker, Smith & Nephew and Karl Storz are the major companies operating in the Global Insufflation Devices Market.